Overview
Status
Active
Registry date
2020-01-17
Share capital
5,000.00 PLN
Registered address
ul. Długa 29, 00-238 Warszawa, Poland
Financials
This entity has not filed any financial documents with the Financial Document Repository (RDF).
Industry
Authorized Representatives
Henryk Czesław Żuber – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Henryk Czesław Żuberage 71 | 82 | $1,107.51 | 82% |
Others | 18 | $243.11 | 18% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2023-11-27 to 2024-05-13.
Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 22, 2024 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $2,005$2,005 | Prezes Banku Gospodarstwa Krajowego | |
| Jan 10, 2024 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $8,018$8,018 | Prezes Banku Gospodarstwa Krajowego | |
| Jun 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Stołecznego Warszawy |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| FamicordtxS.A. | $1,365,068.41 | famicordtx.com | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Explorna Therapeuticssp. z o.o. | $304,662.00 | explorna.com | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| AI Corelabsp. z o.o. | $128,365.55 | aicorelab.com | ||
| ModicaP.S.A. | $103,400.72 | modica.bio | ||
| Bioselsp. z o.o. | $19,100.32 | selol.pl | ||
| Omnisepticasp. z o.o. | $3,475.29 | omniseptica.com | ||
| LASTsp. z o.o. | – | last-skincare.com | ||
| Nawah Scientific Polandsp. z o.o. | – | nawah-scientific.com |
Change history
| Date | Event | |
|---|---|---|
| 2023-12-06 | Address change (Ul. Elektoralna 13/123, 00-137, Warszawa → Ul. Długa 29, 00-238, Warszawa) | |
| 2020-01-17 | Entered in the register |
FAQ
The main business activity of Hoxan focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on January 17, 2020.
The headquarters is located at: ul. Długa 29, 00-238 Warszawa.
The share capital of the company is PLN 5,000 (approx. $1,351).
Last updated: 2026-04-17